eyenovia-logo 3

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
8-K

Report of unscheduled material events or corporate event

Current Reports
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
8-K

Report of unscheduled material events or corporate event

Current Reports
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
EX-101.INS - XBRL INSTANCE DOCUMENT
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports

Contact us for more information

Contact us today to learn more about how our microdosing technology is poised to transform
the standard of care in ophthalmic therapeutic delivery.

295 Madison Ave., Suite 2400, New York, NY 10017     +1 (917) 289-1117

[email protected]